DHHS → node
On September 28, 2022, some rates for Chapter 1, Section 90 have been updated in MIHMS effective October 1, 2022, and are now available for viewing on the Health PAS Online Portal.
See the spreadsheet below for a list of codes with new rates which is available on the Codes & Rates webpage.
November 9, 2022, 7:30-8:30 AM
Via Zoom Webinar!
In a July 22, 2022, e-message the Department indicated Current Procedural Terminology (CPT) code 99188 (application of topical fluoride varnish by a physician or other qualified health professional) would be reimbursed the same rate as Current Dental Terminology (CDT) code D1206, Topical Application of Fluoride Var
Some providers have reported errors when attempting to export claims to Excel from the Health PAS Online Portal. This was due to an issue where wide date parameters in the claims search were timing out during the export to Excel process. This issue has been resolved.
Oct 10, 2022
The Higher Opportunities for Pathways to Employment (HOPE) program, offered through the Maine Department of Health and Human Services (DHHS) Office for Family Independence (OFI), supports Maine parents in pursuing meaningful careers while helping to address Maine’s workforce needs.
The Office of MaineCare Services (OMS), in coordination with their Pharmacy Benefits Manager Change Healthcare (CHC), review data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) to track the epidemic season for Respiratory Syncytial Virus (RSV). Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by RSV in infants. Peak RSV activity typically occurs between November and March.
The Office of MaineCare Services (OMS), in coordination with their Pharmacy Benefits Manager Change Healthcare (CHC), review data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) to track the epidemic season for Respiratory Syncytial Virus (RSV). Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by RSV in infants. Peak RSV activity typically occurs between November and March.
The Office of MaineCare Services (OMS), in coordination with their Pharmacy Benefits Manager Change Healthcare (CHC), review data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) to track the epidemic season for Respiratory Syncytial Virus (RSV). Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by RSV in infants. Peak RSV activity typically occurs between November and March.
The Maine Prescription Monitoring Program (PMP) is notifying all pharmacists and pharmacy staff of an abrupt service disruption event affecting several hundred patients in southern Maine. A pain and addiction medicine clinic in this region has been affected by federal law enforcement action, leaving patients without access to their usual care.
The Maine Prescription Monitoring Program (PMP) is notifying all health care providers and institutions of an abrupt service disruption affecting several hundred patients in southern Maine. A pain and addiction medicine clinic in this region has been affected by federal law enforcement action, leaving patients without access to their usual care.